The world's biggest vaccine maker, has licensed the Oxford vaccine and will soon start manufacturing...
Health Service Division Secretary Abdul Mannan disclosed the development on Tuesday afternoon
The new mid-stage trial will determine whether the vaccine is effective on people between the ages of...
The trial will show whether different Covid-19 doses can be used interchangeably to allow greater flexibility...
All of them have already recovered, DGHS says
Nationwide vaccination program starts February 7
Problems include limited access for poor countries
Cooperation on vaccine is India's duty, MEA says
In the initial six months of the first phase, Beximco will procure five million vaccine doses per...
Bangladesh approves emergency use of Oxford-AstraZeneca vaccine
With this approval, Beximco Pharma can now begin the process to import the vaccine from India
However, the India's largest vaccine manufacturer is yet to secure the permission for exporting Covid-19...
The Oxford vaccine is expected to be approved by medical regulators in days
AstraZeneca expects 4m doses to be available in Britain by the end of next month
The study also found that people with a pre-existing mental illness were 65% more likely to be diagnosed...
This vaccine is one of the most promising and advanced in the world to combat the global pandemic
The device is able to detect the coronavirus and distinguish it from other viruses with high...
AstraZeneca's vaccine is seen as a frontrunner in the global race to deliver an effective vaccine...
The virus that causes Covid-19 attacks many organ systems besides the respiratory issues
The first phase of trialling involved 160 healthy volunteers between 18 and 55
The researchers hope for an 80% success rate
Copyright Ⓒ 2012-2019. 2A Media Limited.
All Rights Reserved.
8/C, FR Tower, Panthapath, Dhaka 1207, Bangladesh.
Kazi Anis Ahmed, Publisher